Browsing: Longevity

A once-a-month GLP-1/GIP drug candidate moves into US trials, signaling a new phase for metabolic medicine and longevity investing. Could…

Paragon’s latest venture targets Alzheimer’s via delivery platform designed to cross the blood-brain barrier. US biotech Korsana Biosciences has emerged…

Evelyne Bischof on why credible training of doctors in healthy longevity is one of the most important health innovations of…

Precision nutrition pioneer L-Nutra will bring fasting-mimicking science and clinically validated longevity programs to the Longevity Show. The Longevity Show…

Fresh backing from Michael J Fox Foundation and Wellcome expands Lario’s calcium channel platform into Parkinson’s disease and PTSD. In…

UK Biobank study connects gray matter differences with sleep disturbance and mental health during post-menopause. For decades, the conversation around…

Wellbeing International Foundation backs cell-free regenerative therapy aimed at restoring the body’s repair language. For years, regenerative medicine was obsessed…

New $1.6m collaboration aims to detect Parkinson’s disease earlier by tracking proteins one molecule at a time. Parkinson’s disease is…

Longevity biotech firm deepens UAE presence, linking AI drug discovery to national genomics and an emerging geroscience ecosystem. Juvenescence has…

Vesalic targets ‘toxic exosome’ identified in ALS patients, suggesting disease biology may not be confined to the brain and CNS.…